Oncology, immunology & rheumatology, rare diseases and CNS are perceived of high commercial attractiveness by respondents in the next 5 years
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · page 27 of 58
The chart uses a 7-point Likert scale. The top 4 categories are highlighted in green.
Consulting deck · market_landscape · analyze_data · overcrowded density
Slide locked Sign in to view
Slide schematic 6/6
chart 1/1 disclaimer 1/1 quote 1/1 source-note 1/1 title 2/2
Components 6
bar-horizontal disclaimer testimonial source-note headline subtitle
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 1
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.